Source: Breathe 2009; 6: 141-145



Rating:

Share or cite this content

Citations should be made in the following way:
A. Brunelli. Commentary: The ERS/ESTS clinical guidelines for evaluating fitness for radical treatment for lung cancer. Breathe 2009; 6: 141-145

Member's Comments

No comment yet.

Related content which might interest you: ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Guideline 2009 Year: 2009 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis. Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Fitness for radical treatment of lung cancer patients Source: Breathe 2011; 7: 221-228 Year: 2011 Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Fitness for radical therapy in lung cancer patients Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020 Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Methodology of formulation of multidiscipliary guidelines for support care management of lung cancer patients Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 The effectiveness of a multidisciplinary approach in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Re-audit of adherence to NICE guidelines on investigation of lung cancer Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Lung function estimation in patients with lung cancer qualified for surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017 A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer Source: ERJ Open Res 2016: 00085-2015 Year: 2016